Medtronic PLC CVG Management Q&A Session for Analysts & Institutional Investors Transcript
All right. So good afternoon, everyone. We'll get started. I'm Ryan Weispfenning, Vice President and Head of Investor Relations at Medtronic. Thanks for coming for to our Cardiac and Vascular Group investor briefing here at the Transcatheter Cardiovascular Therapeutics Conference in San Francisco. Welcome to those joining us around the world on the webcast. And it's good to see another full room here today in San Francisco on what is, I guess, the third and final leg of our North American tour this week.
Yes. Thanks for all of you that survived that. For those that missed it, we do have replays available from our robotic-assisted surgery analyst update that was in Hartford on Tuesday and our Restorative Therapies Group NASS investor briefing from yesterday in Chicago. Those are available on our website, investorrelations.medtronic.com.
Today's webcast event will also be available for replay at that same site. For today's event, I want to note that we could make some comments that may be considered forward-looking statements and actual results
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |